The information contained on this page is intended
for US healthcare professionals only.  Patient siteFREE SAMPLES/COUPONS

The information contained on this page is intended
for US healthcare professionals only.  Patient siteFREE SAMPLES/COUPONS

VAZALORE® is heart protection with the stomach in mindTM

A UNIQUE
DELIVERY SYSTEM
FOR THIS
LIFE-SAVING DRUG

VAZALORE IS SPECIALLY DESIGNED TO HELP REDUCE LOCAL GASTRIC
INJURY WHILE MAINTAINING FULL ASPIRIN BIOAVAILABILITY

VAZALORE is a liquid-filled capsule containing aspirin preassociated with a unique phospholipid to prevent the aspirin from interacting with similar naturally occurring phospholipids in the gastric mucosal barrier, helping to avoid local gastric injury.

THE COMPLEX

VAZALORE contains a proprietary pH-dependent complex of phospholipid excipients and aspirin. Once the capsule dissolves in the stomach, the complex is released, remaining stable in low-pH environments.

THE PROTECTION

While in low-pH environments the aspirin remains sequestered in the phospholipid complex to limit its direct contact with the stomach.

THE ABSORPTION

As pH rises within the GI tract (e.g., across the gastroduodenal mucosal barrier and within the mucosal cells) the aspirin disassociates from the complex and is freed to be quickly and completely absorbed, delivering predictable antiplatelet effects.1

Reference:
  1. Angiolillo DJ, Bhatt DL, Lanza F, et al. Pharmacokinetic pharmacodynamic assessment of a novel, pharmaceutical lipid–aspirin complex: results of a randomized, crossover, bioequivalence study. J Thromb Thrombolysis. 2019;48(4):554-562.

Read VAZALORE 325 mg clinical results
 
 

Access VAZALORE resources
 
 

Opportunity for innovation in
aspirin delivery